Superior MRI outcomes with alemtuzumab compared with subcutaneous interferon β-1a in MS

CARE-MS I and CARE-MS II Coinvestigators

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1464-1472
JournalNeurology
Volume87
Issue number14
DOIs
Publication statusPublished - 4 Oct 2016

Cite this